Purchases and Sales Made in Q4 2022 in Terns Pharmaceuticals, Inc. (TERN)
This table provides information about the institutional ownership of Terns Pharmaceuticals, Inc. (TERN) during Q4 2022. The information is specifically focused on institutions that hold shares of Terns Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-1.06K- 16.09% |
$4.91K - $10.8K
|
5.54K
$33K
|
|
|
May 14, 2024
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-1.09K- 9.11% |
$5.02K - $11.1K
|
10.8K
$64.5K
|
|
|
Feb 13, 2023
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-1.09K- 9.11% |
$5.02K - $11.1K
|
10.8K
$64.5K
|
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-5.91K- 76.51% |
$27.3K - $60.2K
|
1.82K
$10.8K
|
|
|
Feb 14, 2023
Q4 2022
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-9.84K- 7.25% |
$45.4K - $100K
|
126K
$750K
|
|
|
Feb 14, 2023
Q4 2022
|
Fairmount Funds Management LLC
Philadelphia, PA |
SELL
|
- |
-10K- 0.49% |
$46.2K - $102K
|
2.04M
$12.2M
|
|
|
May 21, 2024
Q4 2022
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
SELL
|
- |
-11.5K- 96.78% |
$53.2K - $117K
|
383
$2.28K
|
|
|
Feb 13, 2023
Q4 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-37.3K- 24.51% |
$172K - $380K
|
115K
$685K
|
|
|
Feb 14, 2023
Q4 2022
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-40K- 6.67% |
$185K - $407K
|
560K
$3.34M
|
|
|
Feb 14, 2023
Q4 2022
|
Caas Capital Management LP
New York, NY |
SELL
|
- |
-65.9K- 76.7% |
$304K - $670K
|
20K
$119K
|
|
|
Feb 14, 2023
Q4 2022
|
Samsara Bio Capital, LLC
Palo Alto, CA |
SELL
|
- |
-86.7K- 30.0% |
$401K - $883K
|
202K
$1.21M
|
|
|
Feb 14, 2023
Q4 2022
|
Pura Vida Investments, LLC
New York, NY |
SELL
|
- |
-124K- 16.95% |
$571K - $1.26M
|
605K
$3.61M
|
|
|
Feb 13, 2023
Q4 2022
|
Barclays PLC
London, X0 |
SELL
|
- |
-142K- 21.6% |
$658K - $1.45M
|
517K
$3.08M
|
|
|
Feb 14, 2023
Q4 2022
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-167K- 18.45% |
$771K - $1.7M
|
737K
$4.39M
|